These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2585223)

  • 21. Duration of fever and its relationship to bacteremia in febrile outpatients three to 36 months old. The Occult Bacteremia Study Group.
    Teach SJ; Fleisher GR
    Pediatr Emerg Care; 1997 Oct; 13(5):317-9. PubMed ID: 9368242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occult bacteremia with group B streptococci in an outpatient setting.
    Peña BM; Harper MB; Fleisher GR
    Pediatrics; 1998 Jul; 102(1 Pt 1):67-72. PubMed ID: 9651415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occult bacteremia and septicemia in the febrile child younger than two years.
    Singer JI; Vest J; Prints A
    Emerg Med Clin North Am; 1995 May; 13(2):381-416. PubMed ID: 7737026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome.
    Alpern ER; Alessandrini EA; Bell LM; Shaw KN; McGowan KL
    Pediatrics; 2000 Sep; 106(3):505-11. PubMed ID: 10969095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of bacteremia in febrile children 3 to 36 months of age.
    Isaacman DJ; Shults J; Gross TK; Davis PH; Harper M
    Pediatrics; 2000 Nov; 106(5):977-82. PubMed ID: 11061763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of an observation scale in detecting bacteremia in febrile children three to thirty-six months of age, treated as outpatients. Occult Bacteremia Study Group.
    Teach SJ; Fleisher GR
    J Pediatr; 1995 Jun; 126(6):877-81. PubMed ID: 7776087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of sponging vs acetaminophen for reduction of fever. Sponging Study Group.
    Friedman AD; Barton LL
    Pediatr Emerg Care; 1990 Mar; 6(1):6-7. PubMed ID: 2320489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies for diagnosis and treatment of children at risk for occult bacteremia: clinical effectiveness and cost-effectiveness.
    Lieu TA; Schwartz JS; Jaffe DM; Fleisher GR
    J Pediatr; 1991 Jan; 118(1):21-9. PubMed ID: 1898749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current management of occult bacteremia in infants.
    Mekitarian Filho E; Carvalho WB
    J Pediatr (Rio J); 2015; 91(6 Suppl 1):S61-6. PubMed ID: 26344479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteremia and bacterial infections in highly febrile children without apparent focus.
    Singhi S; Kohli V; Ayyagiri A
    Indian Pediatr; 1992 Oct; 29(10):1285-9. PubMed ID: 1286887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does recent vaccination increase the risk of occult bacteremia?
    Burstein JL; Fleisher GR
    Pediatr Emerg Care; 1994 Jun; 10(3):138-40. PubMed ID: 8058555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotype prevalence of occult pneumococcal bacteremia.
    Alpern ER; Alessandrini EA; McGowan KL; Bell LM; Shaw KN
    Pediatrics; 2001 Aug; 108(2):E23. PubMed ID: 11483833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An analysis of pediatric blood cultures in the postpneumococcal conjugate vaccine era in a community hospital emergency department.
    Sard B; Bailey MC; Vinci R
    Pediatr Emerg Care; 2006 May; 22(5):295-300. PubMed ID: 16714955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A simple index to identify occult bacterial infection in adults with acute unexplained fever.
    Mellors JW; Horwitz RI; Harvey MR; Horwitz SM
    Arch Intern Med; 1987 Apr; 147(4):666-71. PubMed ID: 3827454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occult bacteremia in the emergency department: diagnostic criteria for the young febrile child.
    Crocker PJ; Quick G; McCombs W
    Ann Emerg Med; 1985 Dec; 14(12):1172-7. PubMed ID: 4061989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intramuscular versus oral antibiotic therapy for the prevention of meningitis and other bacterial sequelae in young, febrile children at risk for occult bacteremia.
    Fleisher GR; Rosenberg N; Vinci R; Steinberg J; Powell K; Christy C; Boenning DA; Overturf G; Jaffe D; Platt R
    J Pediatr; 1994 Apr; 124(4):504-12. PubMed ID: 8151462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low risk of bacteremia in febrile children with recognizable viral syndromes.
    Greenes DS; Harper MB
    Pediatr Infect Dis J; 1999 Mar; 18(3):258-61. PubMed ID: 10093948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-reactive protein in febrile children 1 to 36 months of age with clinically undetectable serious bacterial infection.
    Pulliam PN; Attia MW; Cronan KM
    Pediatrics; 2001 Dec; 108(6):1275-9. PubMed ID: 11731648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Predictive factors for invasive pnuemococcal disease: a case-control study].
    Pérez Méndez C; Solís Sánchez G; Miguel Martínez D; La Iglesia Martínez Pd; Viejo De La Guerra G; Martín Mardomingo MA
    An Esp Pediatr; 2002 Oct; 57(4):310-6. PubMed ID: 12392664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parents' utilities for outcomes of occult bacteremia.
    Bennett JE; Sumner W; Downs SM; Jaffe DM
    Arch Pediatr Adolesc Med; 2000 Jan; 154(1):43-8. PubMed ID: 10632249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.